Andere talen WuXi XDC Cayman Inc.

Aandelen

2268

KYG9808A1058

slotkoers Hong Kong S.E. Andere beurzen 00:00:00 08-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
18,42 ^USD	-6,31%		-15,89%	-42,44%

01/05	Winst WuXi XDC Cayman stijgt met 82% in 2023	MT
25/03	WuXi XDC Cayman Inc. Rapporteert resultaten voor het volledige jaar dat eindigde op 31 december 2023	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

WuXi XDC Cayman’s Profit Up 82% in 2023	01/05
WuXi Biologics Reports Solid 2023 Annual Results	27/03
WuXi XDC Delivers Outstanding Performance in 2023 with over 110% Year-On-Year Growth for Both Revenue and Adjusted Net Profit and Achieves Significant Corporate Milestones	26/03
WuXi XDC Cayman Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	25/03
WuXi Shares Fall as Washington Lobbying Group Cuts Ties	14/03
WuXi XDC Cayman’s Shares Close 10% Lower Amid Fear of Potential U.S. Sanctions	07/03
WuXi Companies' Shares Fall Amid Renewed U.S. Sanction Concerns	07/03
WuXi Companies' Shares Rise on Receding Worries About Potential U.S. Sanctions	04/03
WuXi Shares Hit by U.S. Committee Seeking Inquiry, Blacklisting	14/02
US lawmakers call for sanctions on China's WuXi AppTec biotech firm	12/02
WuXi Companies' Shares Slide Amid Concerns Over Proposed U.S. Bill	02/02
WuXi XDC Forecasts 80% Rise in 2023 Profit; Shares Jump 9%	01/02
WuXi XDC Cayman Inc. Provides Earnings Guidance for the Year Ended December 31, 2023	31/01
Wuxi XDC Enters into Partnership with Multitude Therapeutics and HySlink Therapeutics, Novel Linker-Payload Technology Enabling Clients to Accelerate ADC Discovery and Development	31/01
MGI Tech Responds to US BIOSECURE Act	29/01
Wuxi Biologics Clarifies CEO Background Following US Draft Bill	29/01
WuXi AppTec Shares Continue Slide After Company Calls U.S. Draft Bill Findings Inaccurate	29/01
WuXi AppTec Says Findings of U.S. Draft Bill Against Company Aren't Accurate	29/01
WuXi Company Shares Tumble on U.S. Bill Aimed at Chinese Biotech -- Update	26/01
WuXi XDC and Celltrion Sign MOU for Integrated Services for Antibody-Drug Conjugates	24/01

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen WuXi XDC Cayman Inc.

Aandelen

2268

KYG9808A1058

Andere talen

Filters